Tears Naturale II Polyquad

Drug Overview

Tears Naturale II Polyquad is a widely trusted medication classified within the Ocular Lubricant drug class. For patients dealing with the daily annoyance, fluctuating vision, and gritty sensation of mild dry eyes, finding an artificial tear that provides lasting relief without causing stinging or toxicity is a primary clinical goal.

This formulation acts as a non-invasive Targeted Therapy to soothe minor cellular damage, replace missing moisture, and protect the delicate outer layers of the eye. Notably, it utilizes a specialized, tissue-friendly preservative system designed to keep the bottle sterile without destroying the eye’s natural surface cells.

• Generic Name: Dextran 70 and Hypromellose (Hydroxypropyl Methylcellulose)
• US Brand Names: Tears Naturale II Polyquad
• Route of Administration: Topical Drops (instilled directly onto the surface of the eye from a multi-dose bottle)
• FDA Approval Status: FDA-approved as an Over-The-Counter (OTC) ophthalmic medication for the temporary relief of burning and irritation due to dryness of the eye.

What Is It and How Does It Work? (Mechanism of Action)

This medication utilizes two active ingredients—Dextran 70 and Hypromellose—which act as polymeric demulcents. Demulcents are water-soluble polymers that form a soothing, liquid film over irritated mucous membranes. Hypromellose acts as a viscoelastic wetting agent, binding to the dry, water-repelling areas of the corneal epithelium. This acts as an artificial mucous layer, allowing the watery portion of the tears to spread evenly across the eye. Meanwhile, Dextran 70 thickens the tear film, improving its mechanical strength so it does not break apart rapidly between blinks.

A key aspect of this specific formulation’s mechanism involves its preservative: Polyquaternium-1 (Polyquad). Unlike traditional harsh preservatives like Benzalkonium Chloride (BAK), which easily penetrate and destroy corneal cells, Polyquad is a very large molecule. It is specifically engineered to be too large to penetrate mammalian epithelial cells, allowing it to kill bacteria in the bottle while remaining highly biocompatible and non-toxic to the human eye.

FDA-Approved Clinical Indications

Primary Indication

The primary FDA-approved indication for Tears Naturale II Polyquad is the relief of mild dry eye symptoms, including the temporary relief of burning, irritation, and discomfort due to dryness of the eye.

Other Approved & Off-Label Uses

Ophthalmologists and optometrists routinely recommend these gentle lubricants for a wide variety of mild ocular surface conditions requiring consistent management:

• Early-stage Dry Eye Disease (DED)
• Computer Vision Syndrome (Digital Eye Strain)
• Environmental dry eye (due to wind, sun, air conditioning, or dry climates)
• Mild contact lens discomfort (when approved for use with lenses)
• Primary Ophthalmology Indications:
  • Stabilize the Tear Film: By reinforcing the natural aqueous and mucous layers, the drops prevent rapid evaporation, breaking the cycle of mild dryness and inflammation.
  • Preserve Visual Acuity: A dry cornea scatters incoming light, causing blurry and fluctuating vision. By smoothing out the optical surface with a polymer matrix, these drops help maintain crisp, stable visual acuity throughout the day.
  • Protect the Epithelial Barrier: Forms a non-toxic protective shield over the cornea, preventing friction from the eyelids from damaging sensitive surface cells.

Dosage and Administration Protocols

Tears Naturale II Polyquad drops are administered topically to the eye. Consistency is vital; using the drops proactively provides far better protection than waiting until the eyes are already burning.

Specific Instructions for Administration: Wash your hands thoroughly before use. Tilt the head back, gently pull down the lower eyelid to create a pocket, squeeze the drop in, and close the eye gently. Apply light pressure to the inner corner of the eye (technique for punctal occlusion) for 1 minute to keep the medication on the ocular surface. Wait 5 minutes between different drops if using multiple eye medications. If a patient finds they need to use these drops more than 4 to 6 times a day, transitioning to a completely Preservative-Free formulation is strongly recommended to avoid any cumulative preservative toxicity.

“Dosage must be individualized by a qualified healthcare professional.”

Clinical Efficacy and Research Results

Current clinical study data (2020-2026) supports the use of Polyquad-preserved polymer lubricants for managing mild to moderate chronic ocular surface disease. In structured trials evaluating dry eye therapies, patients using formulations that combine demulcents with a biocompatible preservative demonstrate measurable improvements in clinical markers compared to baseline or standard saline tears.

Research highlights that Tear Film Break-Up Time (TBUT)—a vital clinical test measuring how quickly tears evaporate into the air—frequently increases from an unhealthy baseline of 4 seconds to a more stable 7 to 8 seconds. Furthermore, studies utilizing corneal fluorescein staining (which highlights dead cells) show a 1-grade reduction on the Oxford staining scale, indicating successful epithelial healing. Subjectively, patients report a 10- to 15-point improvement on the Ocular Surface Disease Index (OSDI) questionnaire. By stabilizing the tear film safely, this therapy is efficacious in preventing the long-term corneal micro-abrasions that can eventually impair clear vision.

Safety Profile and Side Effects

There is no “Black Box Warning” for Tears Naturale II Polyquad. Because it contains no active pharmacological immunosuppressants or steroids, it boasts a high safety profile for the general public.

Common side effects (>10%)

• Blurred Vision: Mild, temporary blurring immediately upon instillation as the polymer network forms over the cornea (usually clears within 30 to 60 seconds).
• Sticky Eyelashes: A minor, harmless residue left on the eyelid margins after the drops dry.

Serious adverse events

• Microbial Keratitis: A serious bacterial or fungal eye infection, typically caused by touching the dropper tip to a dirty surface, the eyelashes, or the eye itself, thereby contaminating the bottle.
• Allergic Conjunctivitis: Hypersensitivity to the inactive ingredients or the Polyquad preservative, leading to chronic redness, itching, and swelling.

Management Strategies: To minimize the risk of microbial keratitis, patients must practice strict sterile administration techniques. If a patient experiences a stinging or allergic reaction to the preservative, management involves immediately switching to a Preservative-Free alternative.

Research Areas

Direct Clinical Connections: Current ophthalmology research heavily focuses on the impact of various preservatives on goblet cell density. Goblet cells in the conjunctiva produce the vital mucous layer of the tear film. Studies prove that while harsh preservatives like BAK destroy these cells, Polyquad is significantly less toxic, allowing the eye to retain its goblet cell density and promoting the eye’s natural ability to produce healthy tears.

Generalization: Between 2020 and 2026, the global industry has seen a massive shift toward advanced Novel Delivery Systems. While Polyquad is exceptionally safe for mild dry eye, research is actively focused on multi-dose Preservative-Free bottles equipped with advanced internal filtration systems. This allows patients to eventually transition away from chemical preservatives entirely while reducing plastic waste.

Severe Disease & Surgical Integration: For mild disease, drops like Tears Naturale II Polyquad are excellent, but research into end-stage ocular surface disease focuses more on robust ointments or serum tears following corneal transplants (penetrating keratoplasty).

Disclaimer: These studies regarding new multi-dose filtration technologies and advanced surgical integrations are currently in the preclinical or early clinical phase and are not yet applicable to practical or professional clinical scenarios.

Patient Management and Clinical Protocols

Pre-treatment Assessment

• Baseline Diagnostics: Comprehensive measurement of Baseline Visual Acuity, Tonometry (IOP measurement) to rule out high eye pressure as a cause of eye pain, and a detailed Slit-lamp exam to evaluate the health of the cornea.
• Ocular Imaging: Optical Coherence Tomography (OCT) of the anterior segment can be utilized to measure the tear meniscus height, confirming the true volume of tears.
• Specialized Testing: Corneal topography to check for irregular astigmatism caused by dryness, tear film break-up time (TBUT) using fluorescein dye, and meibomian gland evaluation.
• Screening: A thorough history of previous ocular surgeries (like LASIK), underlying autoimmune diseases, or known allergies to generic eye drop preservatives.

Monitoring and Precautions

• Vigilance: Patients should be monitored to ensure dry eye is not worsening despite lubrication. If a patient is taking concurrent topical steroids for inflammation, monitoring for “rebound” inflammation or sudden spikes in IOP following steroid use is mandatory.
• Lifestyle: Environmental modifications are crucial for long-term success. Patients must wear UV protection (sunglasses) outdoors, utilize humidifiers in dry environments, and manage blue light exposure. Practicing the “20-20-20 rule” (looking 20 feet away for 20 seconds every 20 minutes) during screen time encourages healthy blinking. Routine eyelid hygiene (lid scrubs) and dietary supplements (such as Omega-3 fatty acids) heavily support overall ocular health.

“Do’s and Don’ts” list

• DO wash your hands thoroughly with soap and water before handling your eye drops.
• DO gently press on the inner corner of your eye after inserting the drop to keep the medication on the eye longer.
• DO store your eye drops at room temperature and keep the cap tightly closed.
• DON’T let the tip of the bottle touch your eye, eyelashes, fingers, or any other surface.
• DON’T use the drops if the liquid changes color, becomes cloudy, or if the expiration date has passed.
• DON’T ignore worsening eye pain or severely decreased vision; contact your ophthalmologist immediately.

Legal Disclaimer

The medical information provided in this comprehensive guide is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Mild dry eye symptoms can occasionally mimic more serious, vision-threatening conditions. Always seek the advice of your ophthalmologist, optometrist, or other qualified healthcare provider regarding your specific eye health, and before starting, stopping, or changing any treatment regimen.